-
My Account
In App
My Account
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 5 | 1266.25 | 1267.90 | 15 |
| 15 | 1266.20 | 1267.95 | 596 |
| 14 | 1266.00 | 1268.10 | 6 |
| 51 | 1265.25 | 1268.45 | 208 |
| 51 | 1265.10 | 1268.60 | 188 |
| 0 | Total | Total | 0 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 5 | 1266.25 | 1267.90 | 15 |
| 15 | 1266.20 | 1267.95 | 596 |
| 14 | 1266.00 | 1268.10 | 6 |
| 51 | 1265.25 | 1268.45 | 208 |
| 51 | 1265.10 | 1268.60 | 188 |
| 0 | Total | Total | 0 |
As on --
(OI , PRICE )
As on --
| Open | 1,281.10 |
| Previous Close | 1,283.50 |
| Volume | 1,265,233.00 |
| Value (Lacs) | 16,015.32 |
| VWAP | 1,264.59 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 105,648 |
| High | 1,285.10 |
| Low | 1,252.40 |
| UC Limit | 1,411.80 |
| LC Limit | 1,155.20 |
| 52 Week High | 1,405.90 |
| 52 Week Low | 1,020.00 |
| Face Value | 1.00 |
| All Time High | 1,421.49 |
| All Time Low | 43.36 |
| 20D Avg Volume | 1,421,119 |
| 20D Avg Delivery(%) | 63.99 |
| Book Value Per Share | 431.50 |
| Dividend Yield | 0.63 |
| TTM EPS See historical trend | 69.16 (+8.10% YoY) |
| TTM PE See historical trend | 18.30 (Low PE) |
| P/B See historical trend | 2.94 (Low P/B) |
| Sector PE | 40.14 |
*Delayed by 20 seconds.
Stock Score
Get detailed analysis with Moneycontrol Stock Insights.
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
11 out of 17 years Dr Reddys Laboratories has given positive returns in December.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| December | 15.49% (2024) | 3.53% | -9.98% (2014) | -5.33% | 0.40% |
For Indiau2019s weight-loss segment, 2025 is the warm-up, 2026 to be inflection point Dec 23 2025 03:42 PM
Pharma stocks jump up to 5% after US Senate passes Biosecure Act: Check top gainers Dec 19 2025 01:48 PM
Stocks to Watch Today: Wakefit, Corona Remedies, Dr Reddys Labs, Wipro, Aurobindo Pharma, NLC India, Ashoka Buildcon, KEC in focus on 15 December Dec 15 2025 01:56 AM
Trade Spotlight: How should you trade PB Fintech, Century Plyboards, Grasim, Dr Reddys Labs, Zydus Lifesciences, and others on December 12? Dec 12 2025 03:29 AM
Posted by : The Fixed Income
Repost this message
Start Investing with Just 10K now. Add a Strong, Steady Performer to Your Fixed-Income Portfolio 9.02% SAMMAAN CAPITAL LIMITED 2027 ✔️ Coupon: 9.02% ✔️ Rating: AA Stable by CRISIL and ICRA✔️ Tenor: 2y 0M NBFC | High Return Bond | Listed This long-term corporate bond from Samman Capital blends strong ratings with consistent returns, giving your portfolio the stability it deserves. Explore on The Fixed Income and earn fixed returns. : https://www.thefixedincome.com/product/dVJTdVl3PT0=/902-sammaan-capital-limited-2027?utm_source=Moneycontrol&utm_medium=MCForum&utm_campaign=product_list
| Qty 581268 | Price 1250.6 | % Traded 0.07 |
| Qty 581268 | Price 1250.6 | % Traded 0.07 |
| Qty 141606 | Price 1254 | % Traded 0.02 |
| Qty 141606 | Price 1254 | % Traded 0.02 |
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
Sharpest Opinions & Actionable Insights 
Exclusive Webinars 
Research & Expert Technical Analysis 
